UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Turning the Tide Against Regulatory T Cells

Frontiers in oncology, 2019-04, Vol.9, p.279

2019

Volltextzugriff (PDF)

Omicron BA.2 breakthrough infection enhances cross-neutralization of BA.2.12.1 and BA.4/BA.5

Science immunology, 2022-11, Vol.7 (77), p.eade2283

2022

Volltextzugriff (PDF)

Immunity against conserved epitopes dominates after two consecutive exposures to SARS-CoV-2 Omicron BA.1

Cell reports (Cambridge), 2024-08, Vol.43 (8), p.114567, Article 114567

2024

Volltextzugriff (PDF)

Progressive loss of conserved spike protein neutralizing antibody sites in Omicron sublineages is balanced by preserved T cell immunity

Cell reports (Cambridge), 2023-08, Vol.42 (8), p.112888-112888, Article 112888

2023

Volltextzugriff (PDF)

Dynamic Imprinting of the Treg Cell-Specific Epigenetic Signature in Developing Thymic Regulatory T Cells

Frontiers in immunology, 2019-10, Vol.10, p.2382-2382

2019

Volltextzugriff (PDF)

Tumor cell expression of B7-H4 correlates with higher frequencies of tumor-infiltrating APCs and higher CXCL17 expression in human epithelial ovarian cancer

Oncoimmunology, 2019-12, Vol.8 (12), p.e1665460-e1665460

2019

Volltextzugriff (PDF)

An Fc-inert PD-L1×4-1BB bispecific antibody mediates potent anti-tumor immunity in mice by combining checkpoint inhibition and conditional 4-1BB co-stimulation

Oncoimmunology, 2022, Vol.11 (1), p.2030135-2030135

2022

Volltextzugriff (PDF)

DuoBody-CD40x4-1BB induces dendritic-cell maturation and enhances T-cell activation through conditional CD40 and 4-1BB agonist activity

Journal for immunotherapy of cancer, 2022-06, Vol.10 (6), p.e004322

2022

Volltextzugriff (PDF)

813 Combination of HexaBody-CD27 with PD-(L)1 blockade potentiates single-agent activity leading to enhanced human T-cell effector functions in vitro

Journal for immunotherapy of cancer, 2023-11, Vol.11 (Suppl 1), p.A911-A911

2023

Volltextzugriff (PDF)

561 DuoBody®-PD-L1×4–1BB (GEN1046) induces superior immune-cell activation, cytokine production and cytotoxicity by combining PD-L1 blockade with conditional 4–1BB co-stimulation

Journal for immunotherapy of cancer, 2020-11, Vol.8 (Suppl 3), p.A338-A339

2020

Volltextzugriff (PDF)

To Be or Not to Be a T reg Cell: Lineage Decisions Controlled by Epigenetic Mechanisms

Science signaling, 2011-02, Vol.4 (158)

2011

Volltextzugriff (PDF)

To be or not to be a Treg cell: lineage decisions controlled by epigenetic mechanisms

Science signaling, 2011-02, Vol.4 (158), p.pe4

2011

Volltextzugriff (PDF)

WAVE2 suppresses mTOR activation to maintain T cell homeostasis and prevent autoimmunity

Science (American Association for the Advancement of Science), 2021-03, Vol.371 (6536)

2021

Volltextzugriff (PDF)

Active demethylation of the Foxp3 locus leads to the generation of stable regulatory T cells within the thymus

The Journal of immunology (1950), 2013-04, Vol.190 (7), p.3180-3188

2013

Volltextzugriff (PDF)

Regulatory T Cells in Ovarian Cancer Are Characterized by a Highly Activated Phenotype Distinct from that in Melanoma

Clinical cancer research, 2018-11, Vol.24 (22), p.5685-5696

2018

Volltextzugriff (PDF)

Expression of costimulatory and inhibitory receptors in FoxP3 + regulatory T cells within the tumor microenvironment: Implications for combination immunotherapy approaches

Advances in cancer research, 2019, Vol.144, p.193-261

2019

Volltextzugriff (PDF)

Preclinical Characterization and Phase I Trial Results of a Bispecific Antibody Targeting PD-L1 and 4-1BB (GEN1046) in Patients with Advanced Refractory Solid Tumors

Cancer discovery, 2022-05, Vol.12 (5), p.1248-1265

2022

Volltextzugriff (PDF)

Abstract 1846: DuoBody-CD40×4-1BB (GEN1042) induces dendritic-cell maturation and enhances T-cell activation and effector functions in vitro by conditional CD40 and 4-1BB agonist activity

Cancer research (Chicago, Ill.), 2021-07, Vol.81 (13_Supplement), p.1846-1846

2021

Volltextzugriff (PDF)

A signal integration model of thymic selection and natural regulatory T cell commitment

The Journal of immunology (1950), 2014-12, Vol.193 (12), p.5983-5996

2014

Volltextzugriff (PDF)

Foxp3+ regulatory T‐cell homeostasis quantitatively differs in murine peripheral lymph nodes and spleen

European journal of immunology, 2015-01, Vol.45 (1), p.153-166

2015

Volltextzugriff (PDF)

Unique properties of thymic antigen-presenting cells promote epigenetic imprinting of alloantigen-specific regulatory T cells

Oncotarget, 2017-05, Vol.8 (22), p.35542-35557

2017

Volltextzugriff (PDF)

Foxp3 super(+) regulatory T-cell homeostasis quantitatively differs in murine peripheral lymph nodes and spleen

European journal of immunology, 2015-01, Vol.45 (1), p.153-166

2015

Volltextzugriff (PDF)

Abstract 3283: GEN1046 (DuoBody®-PD-L1x4-1BB) in combination with PD-1 blockade potentiates anti-tumor immunity

Cancer research (Chicago, Ill.), 2023-04, Vol.83 (7_Supplement), p.3283-3283

2023

Volltextzugriff (PDF)

Naïve blood monocytes suppress T-cell function. A possible mechanism for protection from autoimmunity

Immunology and cell biology, 2011-01, Vol.89 (1), p.7-13

2011

Volltextzugriff (PDF)

1 – 25 von 29

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(26)
Mit Volltextzugriff
(22)

Publikationsform

Artikel
(29)

Sprache

Englisch
(29)

Erscheinungsjahr

n.n

Thema

Science & Technology
(18)
Life Sciences & Biomedicine
(17)
Animals
(11)
Humans
(10)
Immunology
(9)
Mice
(9)
Oncology
(7)
Cell Biology
(5)
Male
(5)
T-Lymphocytes, Regulatory - Immunology
(5)
T-Lymphocytes, Regulatory - Metabolism
(5)
Autoimmunity
(4)
Cytokines
(4)
Dna Methylation
(4)
Female
(4)
Lymphocytes
(4)
Sars-Cov-2
(4)
T-Lymphocyte Subsets - Immunology
(4)
Thymus Gland - Immunology
(4)
Thymus Gland - Metabolism
(4)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Turning the Tide Against Regulatory T Cells

Omicron BA.2 breakthrough infection enhances cross-neutralization of BA.2.12.1 and BA.4/BA.5

Immunity against conserved epitopes dominates after two consecutive exposures to SARS-CoV-2 Omicron BA.1

Progressive loss of conserved spike protein neutralizing antibody sites in Omicron sublineages is balanced by preserved T cell immunity

Dynamic Imprinting of the Treg Cell-Specific Epigenetic Signature in Developing Thymic Regulatory T Cells

Tumor cell expression of B7-H4 correlates with higher frequencies of tumor-infiltrating APCs and higher CXCL17 expression in human epithelial ovarian cancer

An Fc-inert PD-L1×4-1BB bispecific antibody mediates potent anti-tumor immunity in mice by combining checkpoint inhibition and conditional 4-1BB co-stimulation

DuoBody-CD40x4-1BB induces dendritic-cell maturation and enhances T-cell activation through conditional CD40 and 4-1BB agonist activity

813 Combination of HexaBody-CD27 with PD-(L)1 blockade potentiates single-agent activity leading to enhanced human T-cell effector functions in vitro

561 DuoBody®-PD-L1×4–1BB (GEN1046) induces superior immune-cell activation, cytokine production and cytotoxicity by combining PD-L1 blockade with conditional 4–1BB co-stimulation

To Be or Not to Be a T reg Cell: Lineage Decisions Controlled by Epigenetic Mechanisms

To be or not to be a Treg cell: lineage decisions controlled by epigenetic mechanisms

WAVE2 suppresses mTOR activation to maintain T cell homeostasis and prevent autoimmunity

Active demethylation of the Foxp3 locus leads to the generation of stable regulatory T cells within the thymus

Regulatory T Cells in Ovarian Cancer Are Characterized by a Highly Activated Phenotype Distinct from that in Melanoma

Expression of costimulatory and inhibitory receptors in FoxP3 + regulatory T cells within the tumor microenvironment: Implications for combination immunotherapy approaches

Preclinical Characterization and Phase I Trial Results of a Bispecific Antibody Targeting PD-L1 and 4-1BB (GEN1046) in Patients with Advanced Refractory Solid Tumors

Abstract 1846: DuoBody-CD40×4-1BB (GEN1042) induces dendritic-cell maturation and enhances T-cell activation and effector functions in vitro by conditional CD40 and 4-1BB agonist activity

A signal integration model of thymic selection and natural regulatory T cell commitment

Foxp3+ regulatory T‐cell homeostasis quantitatively differs in murine peripheral lymph nodes and spleen

Unique properties of thymic antigen-presenting cells promote epigenetic imprinting of alloantigen-specific regulatory T cells

Foxp3 super(+) regulatory T-cell homeostasis quantitatively differs in murine peripheral lymph nodes and spleen

Exposure to BA.4/5 S protein drives neutralization of Omicron BA.1, BA.2, BA.2.12.1, and BA.4/5 in vaccine-experienced humans and mice

Abstract 3283: GEN1046 (DuoBody®-PD-L1x4-1BB) in combination with PD-1 blockade potentiates anti-tumor immunity

Naïve blood monocytes suppress T-cell function. A possible mechanism for protection from autoimmunity

Suchergebnisse filtern